P38 inhibitor (4)

p38 MAP kinase inhibitor · Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for P38 inhibitor (4), covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis [Phase 2]